Wahid Rashidzada, MD
Sleep Medicine · Miller Place, NYNPI 1346416021
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $795 and has fallen 80.4% since, to $156 in 2025.
Across 30 payments — averaging $58.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$296
- Harmony Biosciences LLC$289
- Jazz Pharmaceuticals Inc.$225
- Medtronic$159
- Adamas Pharmaceuticals, Inc.$125
- Neurelis, Inc.$125
- plus $530 from 11 others
What the payments were for
- Food & beverage$1,749100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $296 |
| Harmony Biosciences LLC | 3 | $289 |
| Jazz Pharmaceuticals Inc. | 5 | $225 |
| Medtronic | 1 | $159 |
| Adamas Pharmaceuticals, Inc. | 1 | $125 |
| Neurelis, Inc. | 1 | $125 |
| Amneal Pharmaceuticals LLC | 1 | $123 |
| Lundbeck LLC | 1 | $120 |
| Johnson & Johnson(2 entities) | 5 | $85 |
| UCB, Inc. | 1 | $32 |
| AbbVie | 1 | $31 |
| Orthofix Medical, Inc. | 1 | $31 |
| Acadia Pharmaceuticals Inc | 1 | $28 |
| Sandoz | 1 | $24 |
| Amgen | 1 | $22 |
| GE HealthCare | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,749 in reported general payments places this provider in the 55th percentile of 81 sleep medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 12 | $57,631 |
| Droxidopa | 12 | $1,828 |
| Pregabalin | 19 | $1,324 |
| Fludrocortisone Acetate | 12 | $753 |
| Primidone | 47 | $733 |
| Gabapentin | 90 | $686 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 16 | $521 |
| Donepezil Hcl | 68 | $465 |
| Memantine Hcl | 25 | $394 |
| Oxcarbazepine | 14 | $273 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 15 | $213 |
| Divalproex Sodium | 13 | $180 |
| Tizanidine Hcl | 26 | $162 |
| Clonazepam | 12 | $95 |
| Risperidone | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Miller Place
- David RapoportNew York$313K
- Ofer JacobowitzNew York$141K
- Qanta AhmedMineola$83K
- Andrew WestwoodNew York$82K
- Omar BurschtinNew York$71K
- Maha AhmadNew York$38K
- Daniel BaroneNew York$37K
- James ChmielE. Amherst$30K
- Vincent GrbachNew York$21K
- Andrew VargaNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.